Avoro Capital Advisors LLC 13D/13G Filings for Avalo Therapeutics, Inc. (AVTX)

Avoro Capital Advisors LLC 13D and 13G filings for Avalo Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-05-15
08:15 am
Purchase
2026-03-3113GAVALO THERAPEUTICS INC PAR
AVTX
Avoro Capital Advisors LLC1,410,000
5.750%
1,410,000increase
(New Position)
Filing